Celldex Therapeutics, Inc. Net Cash Provided by (Used in) Continuing Operations
Celldex Therapeutics, Inc. (CLDX) reported Net Cash Provided by (Used in) Continuing Operations of $94.15 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-04-29
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was $94.15M.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was -$4.50M, a 102.91% decline year-over-year.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$8.27M.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was -$16.11M.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was -$141.38M, a 197.84% decline from fiscal 2013.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2013 was $144.50M, a 1011.75% increase from fiscal 2012.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2012 was $13.00M.
- Celldex Therapeutics, Inc. net cash provided by (used in) continuing operations for fiscal 2011 was -$9.39M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-03-31 | $94.15M 10-Q · filed 2015-04-29 | $89.64M derived: sum of 2 quarters · filed 2015-04-29 | $81.37M derived: sum of 3 quarters · filed 2015-04-29 | $65.27M derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$12.78M derived: sum of 2 quarters · filed 2015-02-24 | -$28.88M derived: sum of 3 quarters · filed 2015-02-24 | -$141.38M 10-K · filed 2015-02-24 |
| 2014-09-30 | -$8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$24.38M derived: sum of 2 quarters · filed 2014-11-05 | -$136.88M 10-Q · filed 2014-11-05 | $17.90M derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-06-30 | -$16.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$128.60M 10-Q · filed 2014-08-07 | $26.17M derived: sum of 3 quarters · filed 2015-04-29 | $14.90M derived: sum of 4 quarters · filed 2015-04-29 |
| 2014-03-31 | -$112.50M 10-Q · filed 2015-04-29 | $42.28M derived: sum of 2 quarters · filed 2015-04-29 | $31.00M derived: sum of 3 quarters · filed 2015-04-29 | -$18.73M derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-12-31 | $154.78M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $143.50M derived: sum of 2 quarters · filed 2015-02-24 | $93.78M derived: sum of 3 quarters · filed 2015-02-24 | $144.50M 10-K · filed 2015-02-24 |
| 2013-09-30 | -$11.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$61.00M derived: sum of 2 quarters · filed 2014-11-05 | -$10.27M 10-Q · filed 2014-11-05 | -$8.56M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$49.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.00M 10-Q · filed 2014-08-07 | $2.71M derived: sum of 3 quarters · filed 2015-02-24 | $7.34M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $50.73M 10-Q · filed 2014-05-01 | $52.44M derived: sum of 2 quarters · filed 2015-02-24 | $57.06M derived: sum of 3 quarters · filed 2015-02-24 | $52.87M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $6.33M derived: sum of 2 quarters · filed 2015-02-24 | $2.14M derived: sum of 3 quarters · filed 2015-02-24 | $13.00M 10-K · filed 2015-02-24 |
| 2012-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $432.00K derived: sum of 2 quarters · filed 2013-11-08 | $11.29M 10-Q · filed 2013-11-08 | $10.09M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $6.66M 10-Q · filed 2013-08-06 | $5.47M derived: sum of 3 quarters · filed 2014-03-03 | $7.73M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $10.86M 10-Q · filed 2013-05-03 | $9.66M derived: sum of 2 quarters · filed 2014-03-03 | $11.93M derived: sum of 3 quarters · filed 2014-03-03 | $12.62M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.07M derived: sum of 2 quarters · filed 2014-03-03 | $1.76M derived: sum of 3 quarters · filed 2014-03-03 | -$9.39M 10-K · filed 2014-03-03 |
| 2011-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $2.96M derived: sum of 2 quarters · filed 2012-11-02 | -$8.19M 10-Q · filed 2012-11-02 | $3.27M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $690.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$10.46M 10-Q · filed 2012-08-09 | $1.00M derived: sum of 3 quarters · filed 2013-03-08 | |
| 2011-03-31 | -$11.15M 10-Q · filed 2012-05-04 | $312.00K derived: sum of 2 quarters · filed 2013-03-08 | ||
| 2010-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$35.72M 10-K · filed 2013-03-08 | ||
| 2010-09-30 | -$47.17M 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | $12.74M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |